Your browser doesn't support javascript.
loading
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels.
Sideras, Kostandinos; de Man, Robert A; Harrington, Susan M; Polak, Wojciech G; Zhou, Guoying; Schutz, Hannah M; Pedroza-Gonzalez, Alexander; Biermann, Katharina; Mancham, Shanta; Hansen, Bettina E; Bart Takkenberg, R; van Vuuren, Anneke J; Pan, Qiuwei; Ijzermans, Jan N M; Sleijfer, Stefan; Sprengers, Dave; Dong, Haidong; Kwekkeboom, Jaap; Bruno, Marco J.
Afiliação
  • Sideras K; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • de Man RA; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Harrington SM; Mayo Clinic College of Medicine, Department of Immunology, Rochester, MN, USA.
  • Polak WG; Erasmus MC-University Medical Center, Department of Surgery, Rotterdam, The Netherlands.
  • Zhou G; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Schutz HM; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Pedroza-Gonzalez A; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Biermann K; Laboratory of Immunology Research, Medicine, Faculty of Higher Studies Iztacala, National Autonomous University of Mexico, FES-Iztacala, UNAM, Mexico City, Mexico.
  • Mancham S; Erasmus MC-University Medical Center, Department of Pathology, Rotterdam, The Netherlands.
  • Hansen BE; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Bart Takkenberg R; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • van Vuuren AJ; Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, University of Amsterdam, Amsterdam, The Netherlands.
  • Pan Q; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Ijzermans JNM; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Sleijfer S; Erasmus MC-University Medical Center, Department of Surgery, Rotterdam, The Netherlands.
  • Sprengers D; Erasmus MC-University Medical Center, Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, The Netherlands.
  • Dong H; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
  • Kwekkeboom J; Mayo Clinic College of Medicine, Department of Immunology, Rochester, MN, USA.
  • Bruno MJ; Erasmus MC-University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands.
Sci Rep ; 9(1): 10677, 2019 07 23.
Article em En | MEDLINE | ID: mdl-31337865
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Galectinas / Antígeno B7-H1 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Galectinas / Antígeno B7-H1 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article